Quest Diagnostics vs SpaceX: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: Quest Diagnostics and SpaceX side by side

1. 1967Quest Diagnostics

   Metropolitan Pathology Laboratory Founded by Dr. Paul A. Brown

   Dr. Paul A. Brown founded Metropolitan Pathology Laboratory, Inc. in Teaneck, New Jersey, to provide clinical laboratory services to local physicians and hospitals. The company was renamed MetPath, Inc. in 1969.

2. 1982Quest Diagnostics

   Corning Glass Works Acquires MetPath

   Corning Glass Works acquired MetPath and renamed it Corning Clinical Laboratories.

3. 1996Quest Diagnostics

   Spin-off from Corning as Independent Public Company

   On December 31, 1996, Quest Diagnostics became an independent company through a spin-off from Corning and began trading on the NYSE under ticker DGX. Kenneth W. Freeman was appointed CEO.

4. 1999Quest Diagnostics

   Acquisition of SmithKline Beecham Clinical Laboratories

   Quest acquired SmithKline Beecham Clinical Laboratories for approximately $1.3 billion in cash and stock.

5. 2002SpaceX

   SpaceX is founded

   Elon Musk founded Space Exploration Technologies Corp. to reduce launch costs and make Mars settlement technically possible.

6. 2003Quest Diagnostics

   Acquisition of Unilab Corporation for $800 Million

   Quest acquired Unilab Corporation for $800 million, significantly expanding its West Coast presence and adding substantial volume in California and surrounding states.

7. 2005Quest Diagnostics

   Acquisition of LabOne, Inc. for $934 Million

   Quest acquired LabOne, Inc. for $934 million, adding employer drug testing and paramedical testing capabilities that expanded the company's service offerings beyond traditional clinical laboratory testing.

8. 2007Quest Diagnostics

   Acquisition of AmeriPath for Approximately $1.23 Billion

   Quest acquired AmeriPath and its subsidiary Specialty Laboratories for approximately $1.23 billion, adding anatomic pathology and cancer diagnostic testing capabilities that complemented Quest's clinical chemistry strengths.

9. 2008SpaceX

   Falcon 1 reaches orbit

   Falcon 1 became the first privately developed liquid-fuel rocket to reach orbit, rescuing SpaceX after three failed attempts.

10. 2011Quest Diagnostics

    Acquisitions of Athena Diagnostics and Celera Corporation

    Quest acquired Athena Diagnostics (neurodegenerative disease testing) and Celera Corporation (genomics and sequencing), adding advanced diagnostics capabilities in neurology and genetic testing that would become foundational for future growth initiatives.

11. 2012SpaceX

    Dragon reaches the ISS

    Dragon became the first private spacecraft to dock with the International Space Station, proving SpaceX could serve NASA cargo missions.

12. 2014Quest Diagnostics

    Acquisition of Solstas Lab Partners Group for $570 Million

    Quest acquired Solstas Lab Partners Group for $570 million, expanding its geographic footprint in the Southeastern United States and adding hospital outreach laboratory relationships.

13. 2015SpaceX

    Falcon 9 booster landing

    SpaceX landed an orbital-class booster, establishing the technical base for reusable launch economics.

14. 2017SpaceX

    Orbital booster reflight

    SpaceX reflown an orbital-class booster, pushing reuse from demonstration into operating model.

15. 2018Quest Diagnostics

    Launch of QuestDirect Consumer-Initiated Testing

    Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing without a physician order in states where permitted. This marked Quest's entry into the direct-to-consumer diagnostic market.

16. 2020Quest Diagnostics

    COVID-19 Testing Launch and Pandemic Response

    Quest launched COVID-19 testing in March 2020 and by July 2020 had performed more than 9.2 million molecular tests and 2.8 million serology tests. The pandemic created both operational challenges and substantial revenue opportunities for the company.

17. 2020Quest Diagnostics

    Acquisition of Blueprint Genetics for $108 Million

    Quest acquired Blueprint Genetics (Helsinki, Finland) for $108 million, adding genetic testing capabilities for rare diseases and expanding Quest's international genomics expertise.

18. 2020SpaceX

    Crew Dragon carries astronauts

    SpaceX became the first private company to carry astronauts to orbit, restoring U.S. crew launch capability.

19. 2021SpaceX

    Acquired Swarm Technologies

    SpaceX acquired Swarm Technologies.

20. 2022Quest Diagnostics

    Jim Davis Becomes CEO, Succeeding Steve Rusckowski

    Jim Davis succeeded Steve Rusckowski as CEO on November 1, 2022, after serving as Executive Vice President of General Diagnostics. Davis brought experience from GE Healthcare, InSightec, and McKinsey & Company. He became Chairman on April 1, 2023.

21. 2023Quest Diagnostics

    Acquisition of Haystack Oncology and NewYork-Presbyterian Outreach

    Quest acquired Haystack Oncology, a minimal residual disease testing company, and the outreach laboratory operations of NewYork-Presbyterian Hospital for $275 million, expanding advanced oncology diagnostics and health system partnerships.

22. 2023SpaceX

    Starship flight testing begins

    SpaceX conducted the first integrated Starship flight test, starting the high-risk development cycle for its next launch system.

23. 2024Quest Diagnostics

    Acquisition of LifeLabs from OMERS for CAD $1.35 Billion

    Quest completed the acquisition of LifeLabs from OMERS for approximately CAD $1.35 billion (USD ~$1 billion), adding Canada's leading laboratory diagnostic provider with 6,500+ employees, 8+ million online portal users, and approximately CAD $970 million in an…

24. 2025Quest Diagnostics

    Acquisition of Fresenius Medical Care Spectra Laboratories Assets

    Quest completed the acquisition of select clinical testing assets from Fresenius Medical Care's Spectra Laboratories and began providing comprehensive dialysis-related laboratory services for Fresenius-operated centers serving approximately 200,000 patients an…

25. 2025Quest Diagnostics

    Record Financial Performance and Raised 2026 Guidance

    Quest reported record 2025 results with $11.035 billion in revenue (up 11.8%), operating income of $1.556 billion (up 15.6%), and cash from operations of $1.886 billion (up 41.4%).

26. 2025SpaceX

    FY2025 revenue reaches $18.674B

    SpaceX reported $18.674B in FY2025 revenue and a $4.937B net loss in its 2026 prospectus.

27. 2026Quest Diagnostics

    Q1 2026 Results Raise Guidance

    Quest Diagnostics reports Q1 2026 revenues of $2.895B, 9.0% organic revenue growth, and raises FY2026 net revenue guidance to $11.78B-$11.90B.

28. 2026Quest Diagnostics

    Q2 2026 Results and Second Guidance Raise

    Quest reported Q2 2026 revenue of $3.043B (up 10.2%, 10.0% organic) and adjusted diluted EPS of $3.12 (up 19.1%). It raised FY2026 revenue guidance to $11.95B-$12.05B. New York State approved Haystack MRD in the same period.

29. 2026SpaceX

    Prospectus lists SPCX and Starlink scale

    The 2026 prospectus described a Nasdaq listing under SPCX and about 10.3M Starlink subscribers as of March 31, 2026.

Acquisitions

Questions about Quest Diagnostics vs SpaceX